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tions weeks after the cure of the initial episode. Although
CQ remains the ﬁrst line of treatment for patients with vivax
malaria in most of the world, CQ monotherapy is now vir-
tually ineffective in Papua Indonesia with signiﬁcant clinical
resistance apparent throughout the Indonesian archipelago.
Sporadic cases have been reported from South America and
Asia. Unfortunately, the mechanism of P. vivax CQ resistance
is largely unknown and as yet no genetic markers have been
identiﬁed.
Since clinical studies are difﬁcult to carry out in this
species due to factors such as individual variations in patient
immune status, reinfections and frequent relapses, and in
vitro susceptibility assays applicability is limited by lack of
culture methods, the global prevalence of CQ resistance to
P. vivax continues to be poorly deﬁned.
Primaquine, an 8-aminoquinoline compound, is the only
commercially available drug with hypnozoitocidal activity
against P. vivax and is widely used for terminal prophy-
laxis; yet, little is known about how the drug works, if it
works, or how it fails. Reports of true PQ failure and subse-
quent P. vivax relapse are unusual. Most suspected cases can
be ascribed to poor patient adherence. The lack of effec-
tive alternatives to PQ against hypnozoites represents an
important drawback in clinical practice andmay be as opera-
tionally crippling to control efforts against P. vivax, as having
no access to insecticides, bed nets, reliable diagnostics, or
chemoprophylaxis.
Plasmodium vivax malaria will linger as a persistent
and severe challenge to public health as long as our
drug armamentarium remains limited and substantial areas
of our knowledge on its biology, epidemiology, genetics,
metabolism, and mechanisms of resistance to antimalarials,
remain obscure.
doi:10.1016/j.ijid.2010.02.2198
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Mixed infection of inﬂuenza A viruses is common
Y. Furuse1,∗, A. Suzuki1, N. Nukiwa2, N. Fuji 1, H. Oshitani1
1 Tohoku University Graduate School of Medicine, Sendai,
Japan
2 Tohoku University School of Medicine, Sendai, Japan
Background: Reassortment, which is the rearrangement
of viral gene segments in a host cell infected with two
different viruses, is an important mechanism for the evo-
lution of inﬂuenza viruses. A mixed infection of more than
one virus could lead to reassortment. To better understand
the occurrence of quasispecies in one host, we investigated
mixed infection in individual isolates for seasonal inﬂuenza
A viruses using amantadine sensitivity as a marker.
Methods: We cultured viruses with amantadine, and per-
formed sequencing, RFLP, cloning, and quantitative PCR to
detect mixed population in clinical samples.Results: Culturing with amantadine shows evidence of a
high number of mixed populations. When sensitive isolates,
whose M genes were in a certain lineage, were cultured in
medium with amantadine, the viruses with M genes from
a different lineage appeared after several passages. In con-
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rast, the other assays can hardly detect mixed populations.
he proportion of minor viruses in the mixed population may
e too small to be identiﬁed by these assays. We showed
considerably higher proportion (at least 6/11) of mixed
opulations in analyzed samples.
Conclusion: The existence of quasispecies in each isolate
s common. However, the proportion of these, which can be
ess than 1%, is too low to be detected by conventional meth-
ds. Such mixed populations, in which reassortment occurs,
ay have a signiﬁcant role in the evolution of viruses.
oi:10.1016/j.ijid.2010.02.2199
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Background: Despite efforts to enhance inﬂuenza vac-
ination among persons at highest risk of complications,
nﬂuenza remains a health burden in the United States.
vidence indicates that vaccination of elementary school
hildren protects them from inﬂuenza, and reduces trans-
ission. However, there are no published intervention trials
emonstrating the impact of strategies designed to enhance
nﬂuenza vaccination rates speciﬁcally among adolescents.
Objective: Assessing the efﬁcacy of twomulti-component
nterventions designed to enhance inﬂuenza vaccination
ates among adolescents attending middle- and high-schools
n three rural counties in Georgia, U.S.A.
Methods: This study employs a non-randomized, three-
rmed controlled design across 2 years. The three arms
onsist of: 1) a multi-component school-based inﬂuenza
accination intervention condition (County 1), 2) a multi-
omponent provider-based inﬂuenza vaccination condition
County 2), and 3) a standard of care condition (County
). The multi-component interventions each consisted of
structural component (school-based or provider-based
rovision of inﬂuenza vaccination) and an educational com-
onent (a brochure and a school skit), designed to enhance
accine education among adolescents and their parents.
Results: During the 2008 to 2009 inﬂuenza season in
ounty 1, there were 70 students vaccinated out of 370 stu-
ents (18.9%). During the same year in County 2, there were
10 out of 736 students vaccinated (14.9%). In the ﬁrst year,
tudents in County 1 were 25% more likely to be vaccinated
han students in County 2 (RR = 1.26, 95% CI: 0.96-1.66). Dur-
ng the current 2009-2010 inﬂuenza season, in County 1 we
ave vaccinated 114 out of 375 students (30.4%), a 62.2%
ncrease from the previous inﬂuenza vaccination season.
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urrently, in County 2 we have vaccinated 10.5% of students
70 out of 663). For the current inﬂuenza season, students
n County 1 are almost 200% more likely to get vaccinated
han students in County 2 (RR = 2.88, 95% CI: 2.20-3.77).
Conclusion: We have observed a greater percentage of
tudents vaccinated in the school-based intervention than
n the provider-based intervention during the previous and
urrent inﬂuenza seasons (p = 0.0912 and p < 0.0001, respec-
ively). This study has implications for best practices for
ass campaigns during an inﬂuenza pandemic, such as the
urrent H1N1 inﬂuenza pandemic. This study is funded by
DC 5 R18 IP000166.
oi:10.1016/j.ijid.2010.02.2200
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randomized intervention trial of mask use and hand
ygiene to reduce seasonal inﬂuenza-like illness and
nﬂuenza infections among young adults in a university
etting
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Background: Early efforts to decrease transmission of
andemic inﬂuenza will likely rely on nonpharmaceuti-
al interventions (NPIs), because of delays in availability
f suitable vaccines and limited stock of antiviral med-
cations. We conducted a randomized trial to estimate
eductions in inﬂuenza-like illness (ILI) and laboratory-
onﬁrmed inﬂuenza infection associated with use of face
asks combined with hand hygienemeasures and facemasks
lone in a university setting.
Methods: During the 2007-08 inﬂuenza season, 1,111
tudents residing in university residence halls were cluster-
andomized by residence house (N = 37) to either face mask
nd hand hygiene, face mask only, or control arms. Discrete-
ime survival analysis using generalized models estimated
ate ratios, according to study arm, each week and cumu-
atively over the 6-week intervention period, for clinically
eriﬁed ILI and laboratory-conﬁrmed inﬂuenza A or B.
Results: In the mask and hand hygiene group com-
ared with the control group, adjusting for covariates, we
bserved signiﬁcant reductions in ILI incidence during weeks
(RR, 52%, [95% CI, 6%-76%]) and 5 (RR, 62%, [CI, 6%-85%]),
nd a borderline signiﬁcant reduction during week 6 (RR,
0%, [CI, 2%-91%]). For laboratory-conﬁrmed inﬂuenza, both
he face mask only and the face mask and hand hygiene
roups compared to the control showed a reduction in cumu-
ative incidence, however results did not reach statistical
igniﬁcance; polymerase chain reaction (PCR) conﬁrmed
nﬂuenza A or B in 11 out of 49 samples (22%) in the face
ask and hand hygiene group, 16 out of 58 samples (28%) in
he face mask only group, and 18 out of 68 samples (26%) in
he control group.
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Conclusion: These ﬁndings suggest that in shared living
nvironments, the use of face masks and hand hygiene may
educe inﬂuenza-like illnesses.
Trial registration: www.clinicaltrials.gov, Identiﬁer:
CT00490633
oi:10.1016/j.ijid.2010.02.2201
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Background: Worldwide >414,000 cases of pandemic
nﬂuenza H1N1 2009 (2009 H1N1) and nearly 5000 deaths
ave been reported. The 2009 H1N1 was ﬁrst identiﬁed in
exico in April 2009, but spread into neighboring Guatemala
ccurred weeks later. We describe the clinical and epidemi-
logic characteristics of patients with 2009 H1N1 infection
n two sites in Guatemala.
Methods: We analyzed data from an active population-
ased surveillance for clinical pneumonia and inﬂuenza-like
llnesses (ILI) in hospitals and ambulatory clinics, respec-
ively, in the departments of Santa Rosa and Quetzaltenango
n Guatemala from February through September 2009. Clin-
cal and epidemiological information, and nasopharyngeal
wabs were collected from enrolled patients. Specimens
ere tested for inﬂuenza with real-time reverse transcrip-
ase polymerase chain reaction.
Results: We identiﬁed 198 persons with 2009 H1N1 infec-
ion between May and September 2009; 61 (31%) were
ospitalized with pneumonia and six died (case fatality pro-
ortion: 2.7%, 95% conﬁdence interval 0.9%-6.3%). Among
nﬂuenza cases identiﬁed between February and May, the
roportion caused by 2009 H1N1 rose from 0% in February
o 67% in May. By July in any given week 80% to 100% of
nﬂuenza A viruses were 2009 H1N1. The median age of per-
ons with 2009 H1N1 infection was nine years, and among
atients hospitalized with pneumonia six years. Fever >38 ◦C
as documented in 37 (60%) pneumonia patients, 53 (85%)
ersons self-reported fever. Adjusted hospitalization rates
ere highest for children <5 years old (154.9 per 100,000) in
anta Rosa. Fourteen (23%) hospitalized patients with 2009
1N1 were admitted to the intensive care unit (ICU) and
ve (8%) requiredmechanical ventilation. Among children <5
ears, nine (28%) were admitted to the ICU and three (10%)
ied. Underlying chronic conditions were noted in <20% of
atients hospitalized with 2009 H1N1 infection.
Conclusion: Although seasonal inﬂuenza A (H1N1/H3N2)
as circulating prior to widespread 2009 H1N1 transmis-
ion, it was quickly replaced by the 2009 H1N1 virus. The
pidemiology was similar to reports elsewhere except for
he low frequency of underlying disease among hospitalized
